Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Accretive Health, Inc.

Feb 27, 2013, 13:41 ET from Bronstein, Gewirtz & Grossman, LLC

NEW YORK, Feb. 27, 2013 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Accretive Health, Inc. ("Accretive Health" or the "Company") (NYSE: AH).  The investigation focuses on whether the Company and its executives violated federal securities laws.

On February 27, 2013, shares of Accretive health fell 25% to $9.06 in intraday trading, and had fallen more than 26% at one point, in the wake of a release issued late Tuesday that said it would postpone the Company's financial results for the fourth quarter and full year 2012.  The Company said it is evaluating the timing of revenue recognition for its revenue cycle management pacts it has with its clients.  The Company added if a change is warranted, it may have to restate prior financial statements. 

If you are aware of any facts relating to this investigation, or purchased shares of Accretive Health, you can assist this investigation by contacting either Peretz Bronstein or Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email  Those who inquire by e-mail are encouraged to include their mailing address and telephone number.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.  Attorney advertising. Prior results do not guarantee similar outcomes.

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman, 212-697-6484

SOURCE Bronstein, Gewirtz & Grossman, LLC